Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice

Viral Immunology

Volumn 22, Issue 4, 2009, Pages 273-281

  Tao, Pan ^a   Luo, Mengcheng ^a   Zhu, Dandan ^a   Qu, Sanfu ^a   Yang, Zhenhua ^a   Gao, Meng ^a   Guo, Deyin ^a   Pan, Zishu ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CLADISTICS; CONTROLLED STUDY; FEMALE; INFLUENZA VIRUS A H5N1; INSECT CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROTEIN EXPRESSION; VIRUS IMMUNITY; VIRUS LIKE AGENT; VIRUS RECOMBINANT; VIRUS STRAIN;

ANIMALS; ANTIBODY FORMATION; CELL LINE; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; PHYLOGENY; SPODOPTERA; VIRAL MATRIX PROTEINS; VIRION;

AVES; HEXAPODA; MUS; ORTHOMYXOVIRIDAE;

EID: 67849086592     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2009.0017     Document Type: Article

References (47)

1. Antonis, A. F., C. J. Bruschke, P. Rueda, L. Maranga, J. I. Casal, C. Vela, L. A. Hilgers, P. B. Belt, K. Weerdmeester, M. J. Carrondo and J. P. Langeveld, 2006, A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure. Vaccine 24: 5481-5490
2. Bright, R. A., D. M. Carter, C. J. Crevar, F. R. Toapanta, J. D. Steckbeck, K. S. Cole, N. M. Kumar, P. Pushko, G. Smith, T. M. Tumpey and T. M. Ross, 2008, Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE 3: e1501.
3. Bright, R. A., D. M. Carter, S. Daniluk, F. R. Toapanta, A. Ahmad, V. Gavrilov, M. Massare, P. Pushko, N. Mytle, T. Rowe, G. Smith and T. M. Ross, 2007, Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 25: 3871-3878
4. Carrat, F. and A. Flahault, 2007, Influenza vaccine: the challenge of antigenic drift. Vaccine 25: 6852-6862 (Pubitemid 47398929)
5. Chen, Z., S. Kadowaki, Y. Hagiwara, T. Yoshikawa, K. Matsuo, T. Kurata and S. Tamura, 2000, Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine 18: 3214-3222 (Pubitemid 30408197)
6. Claas, E. C., A. D. Osterhaus, R. van Beek, J. C. De Jong, G. F. Rimmelzwaan, D. A. Senne, S. Krauss, K. F. Shortridge and R. G. Webster, 1998, Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351: 472-477
7. de Jong, J. C., E. C. Claas, A. D. Osterhaus, R. G. Webster and W. L. Lim, 1997, A pandemic warning? Nature 389: 554.
8. Deroo, T., W. M. Jou and W. Fiers, 1996, Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine 14: 561-569 (Pubitemid 26173757)
9. Elmowalid, G. A., M. Qiao, S. H. Jeong, B. B. Borg, T. F. Baumert, R. K. Sapp, Z. Hu, K. Murthy and T. J. Liang, 2007, Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees. Proc Natl Acad Sci U S A 104: 8427-8432 (Pubitemid 47175504)
10. Galarza, J. M., T. Latham and A. Cupo, 2005, Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol 18: 244-251 (Pubitemid 40586463)
11. Galarza, J. M., T. Latham and A. Cupo, 2005, Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol 18: 365-372 (Pubitemid 41106015)
12. Grose, C. and K. Chokephaibulkit, 2004, Avian influenza virus infection of children in Vietnam and Thailand. Pediatr Infect Dis J 23: 793-794 (Pubitemid 39063305)
13. Harro, C. D., Y. Y. Pang, R. B. Roden, A. Hildesheim, Z. Wang, M. J. Reynolds, T. C. Mast, R. Robinson, B. R. Murphy, R. A. Karron, J. Dillner, J. T. Schiller and D. R. Lowy, 2001, Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst 93: 284-292 (Pubitemid 32219815)
14. Hasegawa, H., T. Ichinohe, S. Tamura and T. Kurata, 2007, Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic. Expert Rev Vaccines 6: 193-201. (Pubitemid 46607455)
15. Horimoto, T. and Y. Kawaoka, 2001, Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev 14: 129-149 (Pubitemid 32096210)
16. Ito, T. and Y. Kawaoka, 2000, Host-range barrier of influenza A viruses. Vet Microbiol 74: 71-75
17. Jeong, S. H., M. Qiao, M. Nascimbeni, Z. Hu, B. Rehermann, K. Murthy and T. J. Liang, 2004, Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates. J Virol 78: 6995-7003.
18. Jin, H., S. Manetz, J. Leininger, C. Luke, K. Subbarao, B. Murphy, G. Kemble and K. L. Coelingh, 2007, Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets. Vaccine 25: 8664-8672 (Pubitemid 350192061)
19. Johansson, B. E., 1999, Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine. Vaccine 17: 2073-2080
20. Latham, T. and J. M. Galarza, 2001, Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol 75: 6154-6165 (Pubitemid 32553146)
21. LoBue, A. D., L. Lindesmith, B. Yount, P. R. Harrington, J. M. Thompson, R. E. Johnston, C. L. Moe and R. S. Baric, 2006, Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 24: 5220-5234
22. Lu, L., L. Yu and J. Kwang, 2007, Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity. Biochem Biophys Res Commun 358: 404-409 (Pubitemid 46778910)
23. Luo, M., P. Tao, J. Li, S. Zhou, D. Guo and Z. Pan, 2008, Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. J Virol Methods 154: 121-127
24. Mahmood, K., R. A. Bright, N. Mytle, D. M. Carter, C. J. Crevar, J. E. Achenbach, P. M. Heaton, T. M. Tumpey and T. M. Ross, 2008, H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine 26: 5393-5399
25. Matassov, D., A. Cupo and J. M. Galarza, 2007, A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1). Viral Immunol 20: 441-452
26. Morris, S. K., 2006, H5N1 avian influenza, Kampot Province, Cambodia. Emerg Infect Dis 12: 170-171 (Pubitemid 43143560)
27. Network, T. W. H. O. G. I. P. S., 2005, Evolution of H5N1 Avian Influenza Viruses in Asia. Emerging Infectious Diseases 11: 328-330
28. Noad, R. and P. Roy, 2003, Virus-like particles as immunogens. Trends Microbiol 11: 438-444
29. O'Neal, C. M., J. D. Clements, M. K. Estes and M. E. Conner, 1998, Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge. J Virol 72: 3390-3393
30. Organization, W. H., 2007, Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic Vaccines. Wkly Epidemiol Rec. 82: 164-167.
31. Palese, P. and A. Garcia-Sastre, 2002, Influenza vaccines: present and future. J Clin Invest 110: 9-13.
32. Peiris, J. S., W. C. Yu, C. W. Leung, C. Y. Cheung, W. F. Ng, J. M. Nicholls, T. K. Ng, K. H. Chan, S. T. Lai, W. L. Lim, K. Y. Yuen and Y. Guan, 2004, Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363: 617-619
33. Plotnicky, H., D. Cyblat-Chanal, J. P. Aubry, F. Derouet, C. Klinguer-Hamour, A. Beck, J. Y. Bonnefoy and N. Corvaia, 2003, The immunodominant influenza matrix T cell epitope recognized in human induces influenza protection in HLA-A2/K(b) transgenic mice. Virology 309: 320-329 (Pubitemid 36579225)
34. Prel, A., G. Le Gall-Recule, M. Cherbonnel, B. Grasland, M. Amelot and V. Jestin, 2007, Assessment of the protection afforded by triple baculovirus recombinant coexpressing H5, N3, M1 proteins against a homologous H5N3 low-pathogenicity avian influenza virus challenge in Muscovy ducks. Avian Dis 51: 484-489 (Pubitemid 46671339)
35. Pushko, P., T. M. Tumpey, F. Bu, J. Knell, R. Robinson and G. Smith, 2005, Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 23: 5751-5759
36. Pushko, P., T. M. Tumpey, N. Van Hoeven, J. A. Belser, R. Robinson, M. Nathan, G. Smith, D. C. Wright and R. A. Bright, 2007, Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza. Vaccine 25: 4283-4290 (Pubitemid 46646962)
37. Quan, F. S., C. Huang, R. W. Compans and S. M. Kang, 2007, Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 81: 3514-3524 (Pubitemid 46456660)
38. Quan, F. S., D. Steinhauer, C. Huang, T. M. Ross, R. W. Compans and S. M. Kang, 2008, A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine 26: 3352-3361
39. Subbarao, K., A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D. Swayne, C. Bender, J. Huang, M. Hemphill, T. Rowe, M. Shaw, X. Xu, K. Fukuda and N. Cox, 1998, Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279: 393-396 (Pubitemid 28063376)
40. Szucs, T. D., C. Ruef, D. Muller, E. Sokolovic, I. Beeler and W. Ostermayer, 2001, The economic impact of influenza in a university hospital setting. Infect Control Hosp Epidemiol 22: 472-474 (Pubitemid 33031699)
41. Tao, P., M. Luo, R. Pan, D. Ling, S. Zhou, P. Tien and Z. Pan, 2009, Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice. Antiviral Res 81: 253-260
42. Tran, T. H., T. L. Nguyen, T. D. Nguyen, T. S. Luong, P. M. Pham, V. C. Nguyen, T. S. Pham, C. D. Vo, T. Q. Le, T. T. Ngo, B. K. Dao, P. P. Le, T. T. Nguyen, T. L. Hoang, V. T. Cao, T. G. Le, D. T. Nguyen, H. N. Le, K. T. Nguyen, H. S. Le, V. T. Le, D. Christiane, T. T. Tran, J. Menno de, C. Schultsz, P. Cheng, W. Lim, P. Horby and J. Farrar, 2004, Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 350: 1179-1188 (Pubitemid 38339362)
43. Webby, R. J. and R. G. Webster, 2001, Emergence of influenza A viruses. Philos Trans R Soc Lond B Biol Sci 356: 1817-1828
44. Webster, R. G., W. J. Bean, O. T. Gorman, T. M. Chambers and Y. Kawaoka, 1992, Evolution and ecology of influenza A viruses. Microbiol Rev 56: 152-179
45. Webster, R. G. and E. A. Govorkova, 2006, H5N1 influenza-continuing evolution and spread. N Engl J Med 355: 2174-2177
46. Yuen, K. Y., P. K. Chan, M. Peiris, D. N. Tsang, T. L. Que, K. F. Shortridge, P. T. Cheung, W. K. To, E. T. Ho, R. Sung and A. F. Cheng, 1998, Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351: 467-471
47. Zhenhua, Y., T. Pan, Z. Siyu, W. Shuwen and P. Zishu, 2007, Expression of Neuraminidase of H5N1 Subtype Avian Influenza Virus and Production of Polyclonal Antibody. Journal of Wuhan University (Natural Science Edition) 53: 481-484.